跳至主要内容
临床试验/ACTRN12617001066370
ACTRN12617001066370招募中3 期

A multinational, multi-center, randomized, double-blind, active comparator, phase III clinical trial to evaluate the efficacy and safety of donepezil transdermal patch in patients with Alzheimer’s disease

Clinipace Australia Pty Ltd0 个研究点目标入组 588 人开始时间: 2017年7月21日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
588

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 Years 至 85 Years(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Clinipace Australia Pty Ltd

相似试验

进行中(未招募)
不适用
A multi-center, multinational, randomized, double-blind, placebo-controlled, proof of concept trial to assess the effects of a subject-optimized dose of UK-369,003 Modified Release on exercise capacity in subjects with pulmonary hypertension associated with chronic obstructive pulmonary disease. - Not ApplicablePulmonary hypertension associated with chronic obstructive pulmonary disease
EUCTR2004-002216-28-GBPfizer Limited272
进行中(未招募)
不适用
A multi-center, multinational, randomized, double-blind, placebo-controlled, proof of concept trial to assess the effects of a subject-optimized dose of UK-369,003 Modified Release on exercise capacity in subjects with pulmonary hypertension associated with chronic obstructive pulmonary disease. - Not Applicable
EUCTR2004-002216-28-DEPfizer Limited272
进行中(未招募)
不适用
A multi-center, multinational, randomized, double-blind, placebo-controlled, proof of concept trial to assess the effects of a subject-optimized dose of UK-369,003 Modified Release on exercise capacity in subjects with pulmonary hypertension associated with chronic obstructive pulmonary disease.
EUCTR2004-002216-28-BEPfizer Limited272
进行中(未招募)
1 期
A multinational, multi-centre, randomised, double-blind, placebo-controlled, 3-way crossover study in migraine patients, treated with two doses of BGC20-1531 and placebo.
EUCTR2009-010862-43-DKBTG International Ltd100
进行中(未招募)
不适用
A multinational, multi-centre, randomised, double-blind, placebo-controlled, 3-way crossover study in migraine patients, treated with two doses of BGC20-1531 and placebo.Acute migraineMedDRA version: 9.1Level: LLTClassification code 10027599Term: Migraine
EUCTR2009-010862-43-GBBTG International Ltd100